(MedPage Today) — The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ages 12 years and older, GSK announced on Thursday.
Gepotidacin is the first in a new class of antibiotics…
Global study reveals how psychedelics dissolve the brain’s hierarchy
New neuroimaging research suggests that multiple psychedelics affect the brain in a similar way, revealing something like the ‘core signature’...






